Insidra
INSIDRA

Trading Intelligence

SG
Steven Girgenti
Executive ChairmanDirector

Steven Girgenti insider trades: bioAffinity Technologies (BIAF) SEC Form 4 filings

Executive Chairman, bioAffinity Technologies 40 Form 4 filings
40
Form 4 filings
last Jan 14, 2025
31
Other transactions
filings
9
Grants and awards
filings
2
Companies

Companies

Where Steven reports to the SEC

BIAF
BIAFbioAffinity Technologies
Executive Chairman · last filing Jan 14, 2025
No market trades
VYCO
VYCOVycor Medical
Director · last filing Apr 8, 2021
No market trades

About Steven Girgenti's insider trades

Steven Girgenti is Executive Chairman at bioAffinity Technologies (BIAF). Steven has not reported an open-market purchase or sale.

Their filings also include other transactions (31 filings), grants and awards (9 filings), option exercises (1 filing), shares withheld for taxes (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every BIAF insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.